Eflornithine administered by injection is used to treat African sleeping sickness, a disease caused by protozoa (tiny one-celled animals). However, eflornithine hydrochloride applied topically as a cream is the first agent known to help decelerate the rate of excessive hair increment. The keeping abreast year, the European Commission published its commercializing Authorisation. It is marketed under the brand diagnose Vaniqa® and comes as eflornithine hydrochloride 13.9% cream. It is currently not available in New Zealand but is acquirable in the United lands on-duty prescription from your doctor.
Eflornithine works by blocking the enzyme ornithine decarboxylase (ODC) that stimulates hair growth. Eflornithine HCl cream 13.9% has been shown to slow the rate of hair growth in animal and human studies. Studies with eflornithine cream have been limited to treating unwanted hair on the face, around the lips and chin.
A method for temporary hair reduction in women. It appears to be effective in any case, whether the unwanted facial hair is hereditary or is due to medical conditions such as an androgen excess disorder. After 24 weeks of treatment in clinical trials, it was shown to be effective on the upper lip and chin. Treatment of hirsutism:In the 1980s, a company was awarded a patent for the discovery that topical application of eflornithine HCl cream inhibits hair growth. In the 1990s, it conducted dose-ranging studies with eflornithine in hirsute women that established that the drug slackens the grade of nervus facialis hair increment. It then filed away a letters patent for the formulation of eflornithine cream. In July 2000, the FDA granted a U.S. NDA for.
More information: Eflornithine Hcl
Read more>> http://www.lactic-acid-bacteria.net/
No comments:
Post a Comment